AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Nov 13, 2018
29821_dirs_2018-11-13_9237f283-4e6a-4093-8672-cf69659b591e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-11-09
Reporting Person: Butcher Arthur C (SVP&Pres, Endoscopy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-09 | Common Stock | S | 4000.0000 | $38.5000 | Disposed | 10404.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2559.0000 | Indirect |
Footnotes
F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 18
Capital/Financing Update
2026
May 18
Share Issue/Capital Change
2026
May 8
Major Shareholding Notification
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Earnings Release
2026
Apr 22
Regulatory Filings
2026
Apr 2